SynthesisJMIR mental health2025
Telemedicine in Eating Disorder Treatment: Systematic Review.
Synthesis in JMIR mental health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Addressing Schemas, Modes and Interoceptive Disconnection in Chronic Binge Eating Disorder: A Temperament-Informed Schema Therapy Case Series.Clinical psychology & psychotherapyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTelemedicine has emerged as a promising tool to enhance adherence and monitoring in patients with eating disorders (EDs). Traditional face-to-face cognitive therapies remain the gold standard; however, integrating telemedicine may provide additional support and improve patient engagement and retention. Given the increasing use of digital health interventions, it is crucial to assess their safety and effectiveness in complementing conventional treatments.
objectiveWe aimed to evaluate the safety and effectiveness of telemedicine as a complementary tool for cognitive face-to-face therapies to promote adherence and monitoring of patients with EDs.
methodsWe consulted the National Institute for Health and Care Excellence, the Canadian Agency for Drugs and Technologies in Health (now known as Canada's Drug Agency), MEDLINE (Ovid), Embase, Web of Science, Cochrane Library, international HTA database (International Network of Agencies for Health Technology Assessment), CINAHL (EBSCO), and PsycINFO (EBSCO) websites and databases in December 2024 to identify eligible systematic reviews, synthesis reports, or meta-analyses that address telemedicine as a complementary therapy to face-to-face care in patients with EDs. Two researchers performed an independent critical reading of the systematic reviews and assessed the risk of bias using AMSTAR-2 (A Measurement Tool to Assess Systematic Reviews, version 2).
resultsWe initially identified 1004 studies, but only 5 (0.5%) systematic reviews met the inclusion criteria. Email, vodcasts, smartphone apps, and SMS text messaging were the principal telemedicine channels. Telemedicine interventions were safe, helpful, and motivating; improved retention rates and patient-physician communication; and reduced ED symptoms.
conclusionsTelemedicine interventions showed promising, positive findings as a complementary tool for face-to-face ED treatment that must be interpreted cautiously. The limited number of systematic reviews selected and their moderate to critically low quality underscore the need for further research in this area.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.